Journal of the Neurological Sciences
Volume 296, Issue 1 , Pages 34-38 , 15 September 2010

Association of the −344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke

  • Anjana Munshi

      Affiliations

    • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 40 27762776.
    • ,
  • Vandana Sharma

      Affiliations

    • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India
    • ,
  • Subhash Kaul

      Affiliations

    • Nizams Institute of Medical Sciences, Punjagutta, Hyderabad-500082, India
    • ,
  • K. Rajeshwar

      Affiliations

    • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India
    • ,
  • M. Sai Babu

      Affiliations

    • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India
    • ,
  • Gowhar Shafi

      Affiliations

    • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India
    • ,
  • A.N. Anila

      Affiliations

    • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India
    • ,
  • N. Balakrishna

      Affiliations

    • National Institute of Nutrition, Tarnaka, Hyderabad-500007, India
    • ,
  • Suvarna Alladi

      Affiliations

    • Nizams Institute of Medical Sciences, Punjagutta, Hyderabad-500082, India
    • ,
  • A. Jyothy

      Affiliations

    • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India

Received 11 January 2010 ,Revised 19 May 2010 ,Accepted 15 June 2010.

References 

  1. Dichgans M. Genetics of ischemic stroke. Lancet Neurol. 2007;6:149–161
  2. Munshi A, Kaul S. Stroke genetics — focus on PDE4D gene. Int J Stroke. 2008;3(3):188–192
  3. Mollsten A, Stegmayr B, Wiklund PG. Genetic polymorphisms in the renin–angiotensin system confer increased risk of stroke independently of blood pressure: a nested case–control study. J Hypertens. 2008;26(7):1367–1372
  4. Mulatero P, Veglio F, Maffei P, Bondanelli M, Bovio S, Daffara F, et al. Degli Uberti EC, Terzolo M. CYP11B2 344T/C gene polymorphism and blood pressure in patients with acromegaly. J Clin Endocrinol Metab. 2006;9:5008–5012
  5. Rubattu S, Di Angelantonio E, Stanzione R, Zanda B, Evangelista A, Pirisi A, et al. Gene polymorphisms of the renin–angiotensin–aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J Hypertens. 2004;22(11):2129–2134
  6. Verpillat P, Alperovitch A, Cambien F, Besancon V, Desal H, Tzourio C. Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyper intensities. Neurology. 2001;56:673–675
  7. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocrinol Res. 1995;21:437–442
  8. Zhu H, Sagnella GA, Dong Y, Miller MA, Markandu ND, Onipinla A, et al. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens. 2003;21:87–95
  9. Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens. 2003;21:1331–1337
  10. Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H, et al. Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. J Hum Hypertens. 2002;16:789–793
  11. Le Houx JG, Bernard H, Ducharme L, Lefebrre A, Shapcott D, Tremblay A, et al. Control of CYP11B2 gene expression through differential regulation of its promoter by atypical and conventional protein kinase C isoforms. J Biol Chem. 2001;276:8021–8028
  12. Hilers KF, Schmidt BM. Gene variants of aldosterone synthase and hypertension. J Hypertens. 2005;23:1957–1959
  13. Mornet E, Dupont J, Vitek A, White PC. Characterization of two genes encoding human steroid 11 beta-hydroxylase. (P-450(11) beta). J Biol Chem. 1989;264:20961–20967
  14. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32:198–204
  15. White PC, Rainey WE. Polymorphisms in CP11B genes and 11-hydroxylase activity (editorial). J Clin Endocrinol Metab. 2005;90:1252–1255
  16. Paillard F, Chancel D, brand E, benetos A, Thomas F, Czekalski S, et al. Genotype-phenotype relationships for the renin–angiotensin–aldosterone system in a normal population. Hypertension. 1999;34:423–429
  17. White PC, Hautanen A, Kupari M. Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. J Steroid Biochem Mol Biol. 1999;69:409–412
  18. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, et al. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol. 1991;5:1513–1522
  19. Tamaki S, Iwai N, Tsujitay Y, Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension. 1999;33:266–270
  20. Komiya I, Yamada T, Takara M, Asawa T, Shimabukuro M, Nishimori T, et al. Lys (173) ARG and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension. 2000;35:699–703
  21. Barbato A, Russo P, Siani A, Folkerd E, Miller MA, Venezia A, et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multiethnic population. J Hypertens. 2004;22:1895–1901
  22. Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res. 2001;24:105–109
  23. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene cyp11b2. Hypertension. 1999;33:703–707
  24. Casiglia E, Tikhonoff V, Mazza A, Rynkiewicz A, Limon J, Caffi S, et al. C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens. 2005;23:1991–1996
  25. Kato N, Sugiyama T, Morita H, Kurihara H, Furukawa T, Isshiki T, et al. Comprehensive analysis of the renin–angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens. 2000;18(8):1025–1032
  26. Schunkert H, Hengstenberg C, Holme SR, Broeckel U, Luchner A, Muscholl MW, et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation. 1999;99:2255–2260
  27. Brand E, Schorr U, Ringel J, Beige J, Distler A, Sharma AM. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST). J Hypertens. 1999;17(11):1563–1567
  28. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41
  29. Munshi A, Shehnaz S, Kaul S, Pulla Reddy B, Alladi S, Jyothy A. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. J Neurol Sci. 2008;272:132–135
  30. Kupari M, Hautanen A, Lankinen I, Koskinen P, Virolainen J, Nikkila H, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function. Circulation. 1998;97:569–575
  31. Xu XJ, Wang SZ, Lin RY, Wang XF, Liang XH, Wen H, et al. Association of the T-344C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjdang Kazakh isolated group. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;2:622–624
  32. Ylitalo A, Juhani Airaksinen KE, Hautanen A, Kupari M, Carson M, Virolainen J, et al. Baroreflex sensitivity and variants of the renin angiotensin system genes. J Am Coll Cardiol. 2000;35:194–200
  33. Sookoian S, Gianotti TF, Gonzalez CD, Pirola CJ. Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens. 2008;25:5–13
  34. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens. 1998;11(7):856–860
  35. Brand E, Chatelain N, Mulatero P, Féry I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32:198–204
  36. Benetos A, Poirier O, Guyene TT, Gautier S, Pojaga L, Cambien F. Genetic determination of plasma aldosterone levels. Hypertension. 1997;30:P66
  37. Fardella CE, Hum DW, Rodriguez H, Zhang G, Barry FL, Ilicki A, et al. Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency. J Clin Endocrinol Metab. 1996;81:321–326
  38. Tanahashi H, Mune T, Takahashi Y, Iraj M, Sawa T, Morita H, et al. Association of Lys 173 Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone producing adenomas. J Clin Endocrinol Metab. 2005;90:6226–6231
  39. Iwai N, Kajimoto K, Tomoike H, Takashima N. Polymorphism of CYP11B2 determines salt sensitivity in Japanese. Hypertension. 2007;49:825–831
  40. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol. 1997;11(5):638–649
  41. Brenner D, Labreuche J, Pico F, Scheltens P, Poirier O, Cambien F, et al. The renin–aldosterone system in cerebral small vessel disease. J Neurol. 2008;255:993–1000
  42. Kaul S, Sunitha P, Suvarna A, Meena AK, Uma M, Reddy JM. Subtypes of ischemic stroke in a metropolitan city of south India (one year data from a hospital based stroke registry). Neurol India. 2002;50(Suppl):S8–S14
  43. Pandian JD, Jaison Ashish, Sukhbinder SD, Kalra G, Shamsher S, Abraham DG. Public awareness of warning symptoms, risk factors and treatment of stroke in North West India. Stroke. 2005;36:644–648
  44. Kaul S. Stroke in India. ACNR. 2007;7(5):23–24

PII: S0022-510X(10)00261-3

doi: 10.1016/j.jns.2010.06.013

Journal of the Neurological Sciences
Volume 296, Issue 1 , Pages 34-38 , 15 September 2010

Article Tools